Pablo Mando, Editor-in-Chief of Oncologia Clínica, shared a post on X:
“Take home messages of a comprehensive overview on response and toxicity prediction biomarkers in ADC
Few currently available biomarkers to guide selection
A growing list of potential markers
Need of Mechanisms to Discover and Validate biomarkers.”
Find More Posts Featuring Pablo Mando on OncoDaily.